Pharmacodynamic effect of clopidogrel therapy and switching to cilostazol in patients with the CYP2C19 loss-of-function allele (ACCEL-SWITCH) study.

Published

Journal Article (Letter)

Full Text

Cited Authors

  • Jeong, Y-H; Park, Y; Muse, WC; Kwon, TJ; Koh, J-S; Hwang, S-J; Kwak, CH; Hwang, J-Y

Published Date

  • August 2012

Published In

Volume / Issue

  • 10 / 8

Start / End Page

  • 1685 - 1688

PubMed ID

  • 22612904

Pubmed Central ID

  • 22612904

Electronic International Standard Serial Number (EISSN)

  • 1538-7836

International Standard Serial Number (ISSN)

  • 1538-7933

Digital Object Identifier (DOI)

  • 10.1111/j.1538-7836.2012.04788.x

Language

  • eng